PROSTATE CANCER RESEARCH
Prostate Cancer Research aims to save lives and improve the quality of life for all those affected by prostate cancer through funding research and empowering patients.
Objects
THE PROMOTION OF MEDICAL AND SCIENTIFIC RESEARCH INTO THE CAUSES AND TREATMENT OF CANCER AND RELATED DISEASES AND DISSEMINATION OF THE USEFUL RESULTS THEREOF.
Financial health, per its FY2026 accounts
The accounts state that the charity achieved a healthy surplus with total income increasing by 45% to £7.5 million. Free unrestricted reserves rose to £1.53 million, which the trustees note is progress towards but still below their stated policy target of £1.7 million. The charity reports adequate resources to continue as a going concern with a strengthened liquidity position.
What the accounts disclose
“Between £120,001 - £130,000 1 -”
“The cost of raising funds was equivalent to 20.5% of total income (2025: 21.0%), broadly stable year on year.”
“During the year the charity incorporated a trading company in England and Wales owning 100% of the shareholding. The subsidiary undertaking, Prostate Progress Limited, with £1 share capital has been dormant at the year end.” — page 46
Policies the charity declares
- Campaigns and political activity policy and procedures
- Complaints handling
- Complaints policy and procedures
- Conflicting interests
- Engaging external speakers at charity events policy and procedures
- Financial reserves policy and procedures
- Internal charity financial controls policy and procedures
- Internal risk management policy and procedures
- Investing charity funds policy and procedures
- Investment
- Paying staff
- Risk management
- Safeguarding policy and procedures
- Serious incident reporting policy and procedures
- Trustee conflicts of interest policy and procedures
- Trustee expenses policy and procedures
- Volunteer management
From the charity’s annual return (Part A, self-declared)
Self-declared on the annual return for the financial year ending 31/03/2026
- Volunteers: 150
- Employees paid over £60,000: 13 (£60,001–£70,000: 5; £70,001–£80,000: 2; £80,001–£90,000: 3; £90,001–£100,000: 1; £100,001–£110,000: 1; £120,001–£130,000: 1)
- Has a trading subsidiary
- Grant-making is its main activity
Self-declared on the annual return for the financial year ending 31/03/2025
- Volunteers: 150
- Employees paid over £60,000: 9 (£60,001–£70,000: 3; £70,001–£80,000: 3; £80,001–£90,000: 1; £90,001–£100,000: 1; £110,001–£120,000: 1)
- Grant-making is its main activity
Self-declared on the annual return for the financial year ending 31/03/2024
- Volunteers: 150
- Government income: £525,466 — grants £525,466 (1); 11% of the £4,907,018 total gross income on the same return
- Employees paid over £60,000: 8 (£60,001–£70,000: 5; £70,001–£80,000: 1; £90,001–£100,000: 1; £110,001–£120,000: 1)
- Grant-making is its main activity
Annual return filing dates (Charity Commission record)
Of its last 5 annual returns with a recorded received date, 1 was received after the due date: year ending 31/03/2024 (received 27/03/2025, 55 days after the 31/01/2025 due date).
Structured financials (annual return, FY ending 31/03/2026)
Register events
- Received assets from another charity (14/08/2026)
- Received assets from another charity (11/07/2025)
- Received assets from another charity (20/12/2021)
Trustees
- Alex Davis
- Clare Phillips
- Jonathan Badger
- Karen Blyth
- Louisa Fleure
- MARCELLA ANGELA TURNER
- MARK CLARK
- Magnus Hibbert
- Neil Mackison
- Nicholas Jones
- Prof Simon Crabb
- Professor Philip Cornford
- Richard Collier
- Soeren Fryland Moeller
- Suman Shirodkar
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/03/2026 | £7.5m | £6.7m |
| 31/03/2025 | £5.2m | £6.1m |
| 31/03/2024 | £4.9m | £4.1m |
| 31/03/2023 | £3.0m | £3.5m |
| 31/03/2022 | £2.7m | £2.6m |
Common questions
Is PROSTATE CANCER RESEARCH financially healthy?
Per its FY2026 accounts: The accounts state that the charity achieved a healthy surplus with total income increasing by 45% to £7.5 million. Free unrestricted reserves rose to £1.53 million, which the trustees note is progress towards but still below their stated policy target of £1.7 million. The charity reports adequate resources to continue as a going concern with a strengthened liquidity position. Its FY2026 accounts were audited by Moore Kingston Smith LLP.
What does the highest-paid employee of PROSTATE CANCER RESEARCH earn?
Per its FY2026 accounts, the highest-paid employee was in the £120,001 - £130,000 band.
Who funds PROSTATE CANCER RESEARCH?
Funders whose own accounts filings name PROSTATE CANCER RESEARCH as a grant recipient include BREAST CANCER NOW, PHILIP KING CHARITABLE TRUST, DAVID LISTER CHARITABLE TRUST, PETER STORMONTH DARLING CHARITABLE TRUST, THE WILL CHARITABLE TRUST.
Known funders
Government & lottery funding
| Funder | Date | Amount | Purpose |
|---|---|---|---|
| The National Lottery Community Fund | 18/12/2024 | £496k | Empowering People with Prostate Cancer - Phase 2 |
Funders of similar charities
| Funder | Similar charities funded | Amount to them |
|---|---|---|
| THE FREDDIE GREEN AND FAMILY CHARITABLE FOUNDATION | 2 | £45k |
| SANDRA CHARITABLE TRUST | 2 | £9k |
| THE W E DUNN TRUST | 2 | £3k |
| THE ICELAND FOODS CHARITABLE FOUNDATION | 1 | £500k |
| THE THOMPSON FAMILY CHARITABLE TRUST | 1 | £500k |
| MOVEMBER EUROPE | 1 | £318k |
| THE 3 TS CHARITABLE TRUST | 1 | £225k |
| THE CONSTANCE TRAVIS CHARITABLE TRUST | 1 | £220k |
Charities like this
- PROSTATE CANCER UK
- THE PROSTATE PROJECT
- PROST8 UK
- NATIONAL CANCER RESEARCH INSTITUTE
- CANCER RESEARCH WALES
- THE NATIONAL FEDERATION OF PROSTATE CANCER SUPPORT GROUPS
Side by side with its peers
| Charity | Income | Top pay band | Staff >£60k | Reserves vs policy | Fundraising cost | Going concern |
|---|---|---|---|---|---|---|
| PROSTATE CANCER RESEARCH | £7.5m | £120,001 - £130,000 | — | unclear | 20.5% | no doubt |
| PROSTATE CANCER UK | £45.5m | — | — | above | — | no doubt |
| THE PROSTATE PROJECT | £493k | — | 0 | unclear | — | no doubt |
| PROST8 UK | £93k | — | 0 | unclear | — | no doubt |
| NATIONAL CANCER RESEARCH INSTITUTE | £1.6m | — | — | above | — | no doubt |
| CANCER RESEARCH WALES | £5.9m | — | — | unclear | — | no doubt |